59 Days
Source:
الدستور
Food and Drug Administration Registers First Locally Developed Pneumococcal Vaccine
The Jordan Food and Drug Administration announced the registration of the first locally developed vaccine against pneumococcus, which is the TQ-PCV VAX 13-valent Pneumococcal Polysaccharide Conjugate Vaccine 0.5 ml, in collaboration with the Chinese company Walvax. The vaccine aims to protect children from three months to five years old from diseases caused by 13 strains of pneumococcal bacteria. This achievement comes after the completion of technical and standard evaluation processes and represents an important step in developing the national pharmaceutical industry and strengthening drug security in Jordan. It also contributes to increasing the competitiveness of the pharmaceutical sector and establishing the country as a regional hub for pharmaceutical innovation.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)